Inspiratory Muscular Training

This study has been completed.
Sponsor:
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
Information provided by (Responsible Party):
Daniella Cunha Brandao, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier:
NCT01593007
First received: May 3, 2012
Last updated: June 12, 2012
Last verified: October 2011
  Purpose

Objectives: To evaluate regional lung ventilation distribution in patients suffering from chronic heart failure (CHF) after completing inspiratory muscle training (IMT) and correlate it with functional capacity and quality of life among these individuals. Methods and Results: Nineteen CHF patients were randomly assigned to two groups: Control and IMT. Before and after muscle training, subjects were submitted to assessment protocol for respiratory muscles, digital spirometry, optoelectronic plethysmography (OEP), the six-minute walk test (6MWT) and a quality of life questionnaire (MLHFQ). There was no difference in lung function following the 12-week training period in either group. However, the IMT group showed an increase in actual and predicted MIP, higher MLFHQ score and greater distance walked in the 6MWT, as well as a reduction in the Borg scale after the 6 MWT in relation to the control. For the OEP, IMT group members exhibited higher values for total chest wall volume (Vcw), abdominal rib cage volume (Vrc,a) and abdominal volume (Vab) when compared to the control. Conclusions: For patients with CHF, IMT proved efficient in improving muscle strength, functional capacity and quality of life. The present study also analyzed the distribution behavior of lung volumes for the thoracoabdominal system in this population, showing that larger abdominal rib cage and abdomen volumes may result in more effective diaphragmatic contraction.


Condition Intervention
Heart Failure
Other: Inspiratory muscle training
Other: Control group

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: REGIONAL LUNG VENTILATION DISTRIBUTION AMONG INDIVIDUALS WITH CHRONIC HEART FAILURE AFTER AN INSPIRATORY MUSCLE TRAINING PROGRAMM: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Resource links provided by NLM:


Further study details as provided by Universidade Federal de Pernambuco:

Primary Outcome Measures:
  • Respiratory muscles [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
    In order to evaluate inspiratory muscle strength, a digital manometer was used (MVD-300, Globalmed, Brazil) connected to a mouthpiece with a 2mm opening to reduce the influence of pressure caused by glottal closure. In a sitting position, each patient performed up to six maneuvers to obtain MIP, from residual volume (RV) to total functional capacity (TFC), considering the best of three maneuvers with < 10% variation between them


Secondary Outcome Measures:
  • Assessment of respiratory mechanics by Optoelectronic Plethysmography [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
    The optoelectronic plethysmography system (OEP) of BTS Bioengineering (Italy) was employed in this study. To that end, a calibration instrument was used, containing three axes connected to reflective markers. This phase does not require participation by the individual to be examined. This creates a three-dimensional model, dividing the thoracoabdominal system into three parts: pulmonary rib cage (RCp), abdominal rib cage (RCa) and the abdomen (AB).

  • Evaluation of submaximal functional capacity [ Time Frame: 3 mounths ] [ Designated as safety issue: Yes ]
    Functional capacity was assessed by the six-minute walk test (6MWT), according to the protocol published by the American Thoracic Society (ATS).

  • Quality of Life Questionnaire: Minnesota Living With Heart Failure Questionnaire (MLHFQ) [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
    The MLHFQ is a questionnaire validated for the Brazilian population, consisting of 21 questions regarding limitations frequently associated with the extent to which heart failure has affected patient's lives in the previous month. Each question is attributed a value from 0 (zero) to 5 (five), with the highest score indicating worse quality of life. The total score is calculated by adding the 21 items, with a possible interval between 0 and 105.


Enrollment: 19
Study Start Date: June 2010
Study Completion Date: May 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Inspiratory Muscle Training
Inspiratory Muscle Training
Other: Inspiratory muscle training
All participants were instructed to use a Threshold® trainer for 30min a day, seven times a week over 12 consecutive weeks.10 Patients in the Control Group used a Threshold ® device without resistance, making them blind to the treatment. For the treatment group, inspiratory resistance of the Threshold® trainer was 30% of MIP, adjusted on a weekly basis to remain constant.
Placebo Comparator: Control group
Patients from the control group were also assessed weekly to ensure homogenization of the learning effect for the manometer maneuver.
Other: Control group
Patients from the control group were also assessed weekly to ensure homogenization of the learning effect for the manometer maneuver.

  Eligibility

Ages Eligible for Study:   21 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • sedentary adults diagnosed with functional class II and II CHF in accordance with the New York Heart Association (NYHA);
  • in stage B or C according to American College of Sports Medicine guidelines;
  • with left ventricle ejection fraction lower than 45% (evaluated by echocardiogram in a period ≤ 1 year);
  • cardiomegaly confirmed by increased left ventricle end-diastolic (LVDD) and end-systolic diameter (LVESD) associated with a cardiac index (CI) >0.5 according to chest X-rays;
  • inspiratory muscle weakness (MIP <70% of predicted values);
  • clinical stability with no change in medication for at least three months and sedentary (no regular physical activity performed in the previous six months or not accumulating 30 minutes or more of moderate physical activity - 3 to 6 METs - on most week days).

Exclusion Criteria:

  • patients exhibiting unstable angina, myocardial infarction or prior heart surgery up to three months before beginning the investigation;
  • orthopedic, infectious or chronic metabolic diseases;
  • treatment with steroids, hormones or chemotherapy;
  • ratio between forced expiratory volume in one second and forced vital capacity (FEV1/FVC) < 70% of predicted, characterizing an obstructive respiratory disorder;
  • respiratory diseases, smokers and ex-smokers with a history of cigarettes/day for more than 10 years.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01593007

Locations
Brazil
Departamento de Fisioterapia-Universidade Federal de pernambuco
Recife, Pernambuco, Brazil
Sponsors and Collaborators
Universidade Federal de Pernambuco
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
  More Information

Additional Information:
Publications:
Responsible Party: Daniella Cunha Brandao, PhD, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier: NCT01593007     History of Changes
Other Study ID Numbers: tese02
Study First Received: May 3, 2012
Last Updated: June 12, 2012
Health Authority: Brazil: Ethics Committee

Keywords provided by Universidade Federal de Pernambuco:
Heart failure
respiratory muscles
optoelectronic plethysmography

Additional relevant MeSH terms:
Heart Failure
Cardiovascular Diseases
Heart Diseases

ClinicalTrials.gov processed this record on October 30, 2014